Remus Pharma.

Market Cap: Micro Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE0O5T01011
NSEID: REMUS
BSEID:

INR

719.95

4.2 (0.59%)

BSENSE

Dec 18

BSE+NSE Vol: 2100

{
  "main_header": {
    "sid": 1003851,
    "name": "Remus Pharma.",
    "stock_name": "Remus Pharma.",
    "full_name": "Remus Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/remus-pharma",
    "exchange": 1,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "719.95",
    "chg": 4.2,
    "chgp": "0.59%",
    "dir": 1,
    "prev_price": "715.75",
    "mcapval": "843.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "REMUS",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE0O5T01011",
    "curr_date": "Dec 18",
    "curr_time": "",
    "bse_nse_vol": 2100,
    "exc_status": "Active",
    "traded_date": "Dec 18, 2025",
    "traded_date_str": "2025 12 18",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/remus-pharma-1003851-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Is Remus Pharma. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-remus-pharma-technically-bullish-or-bearish-3740551",
        "imagepath": "",
        "date": "2025-12-02 09:14:56",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Technical Trend Overview</strong></p>\n<p>As of 1 December 2025, Remus Pharma’s technical trend shifted from outright bearish to mildly bearish. This subtle change signals a tentative easing of downward pressure but stops short of confirming a bullish reversal. The stock’s current price stands at ₹713.45, having risen from the previous close of ₹690.00, indicating some short-term buying interest. However, this remains well below its 52-week high of ₹1,360.00, highlighting significant depreciation over the past year.</p>\n<p><strong>Key Technical Indicators: Mixed Signals</strong></p>\n<p>The Moving Average Convergence Divergence (MACD) on the weekly chart is mildly bullish, suggesting some momentum building in the near term. Conversely, the daily moving averages remain bearish, reflecting persi..."
      },
      {
        "title": "How has been the historical performance of Remus Pharma.?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-remus-pharma-3694332",
        "imagepath": "",
        "date": "2025-11-12 23:35:06",
        "description": "Answer:\nThe historical performance of Remus Pharma shows significant growth from the fiscal year ending March 2024 to March 2025.\n\nBreakdown:\nIn the fiscal year ending March 2025, Remus Pharma reported net sales of 620.36 Cr, a substantial increase from 212.94 Cr in March 2024. The total operating income mirrored this growth, reaching 620.36 Cr compared to 212.94 Cr the previous year. Total expenditure also rose to 574.67 Cr from 183.98 Cr, with notable increases in the purchase of finished goods and other expenses. Operating profit (PBDIT) increased to 50.67 Cr from 31.79 Cr, while profit before tax rose to 47.34 Cr from 30.17 Cr. The profit after tax also saw an increase, reaching 38.42 Cr compared to 24.28 Cr in the prior year. The consolidated net profit for March 2025 was 29.07 Cr, up from 20.52 Cr. Earnings per share improved significantly to 24.68 from 17.45, and the book value per share adjusted to ..."
      },
      {
        "title": "Why is Remus Pharma. falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-remus-pharma-fallingrising-3672718",
        "imagepath": "",
        "date": "2025-11-05 00:19:54",
        "description": "As of 04-Nov, Remus Pharmaceuticals Ltd is experiencing a price increase, with the current price at 812.50, reflecting a rise of 42.45 or 5.51%. The stock has shown strong performance today, outperforming its sector by 5.98%. Additionally, the stock's delivery volume has significantly increased by 164.55% compared to the 5-day average, indicating rising investor participation. In terms of returns, the stock has gained 23.91% over the past week, while it has increased by 11.23% over the past month. However, it is important to note that the stock is still down 34.93% year-to-date and 36.09% over the past year, suggesting a challenging longer-term trend.\n\nIn the broader market context, the Sensex has experienced a decline of 1.31% over the past week and an increase of 2.83% over the past month, indicating that while the market has been relatively stable, Remus Pharmaceuticals has significantly outperformed it ..."
      },
      {
        "title": "Is Remus Pharma. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-remus-pharma-technically-bullish-or-bearish-3669373",
        "imagepath": "",
        "date": "2025-11-04 08:48:58",
        "description": "As of 3 November 2025, the technical trend has changed from bearish to mildly bearish. The current stance is mildly bearish with weak strength. The weekly MACD is bearish, and the daily moving averages also indicate a bearish trend. While the monthly RSI is bullish, the overall indicators such as the Bollinger Bands and KST on the weekly time frame are mildly bearish. Dow Theory shows a mildly bullish signal on the weekly but remains bearish on the monthly, indicating mixed signals. The recent price action shows a recovery from the previous close, but the overall technical picture leans towards bearish sentiment...."
      },
      {
        "title": "Why is Remus Pharma. falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-remus-pharma-fallingrising-3668498",
        "imagepath": "",
        "date": "2025-11-03 23:44:00",
        "description": "As of 03-Nov, Remus Pharmaceuticals Ltd is experiencing a price increase, with its current price at 770.05, reflecting a rise of 50.0 or 6.94%. The stock has shown strong performance today, outperforming its sector by 5.64%. In terms of returns, over the past week, the stock has increased by 15.07%, while it has seen a more modest gain of 5.42% over the past month. However, it is important to note that the stock has significantly underperformed on a year-to-date basis, with a decline of 38.33%, and a yearly decline of 41.49%. The stock's moving averages indicate that while it is currently above the 5-day and 20-day averages, it remains below the longer-term averages of 50-day, 100-day, and 200-day, suggesting mixed signals regarding its longer-term trend. Additionally, there has been a notable decrease in investor participation, with delivery volume falling by 35.75% against the 5-day average, which could i..."
      },
      {
        "title": "Why is Remus Pharma. falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-remus-pharma-fallingrising-3663182",
        "imagepath": "",
        "date": "2025-10-31 23:46:31",
        "description": "As of 31-Oct, Remus Pharmaceuticals Ltd is experiencing a price increase, currently at 720.05, with a change of 32.0, representing a 4.65% rise. The stock has outperformed its sector today by 5.1%, indicating strong investor interest. Additionally, the delivery volume has significantly increased by 105.04% compared to the 5-day average, suggesting rising investor participation. However, while the stock is performing well in the short term, it has seen a decline of 42.34% year-to-date and 44.97% over the past year, which highlights ongoing challenges despite today's positive movement.\n\nIn the broader market context, the Sensex has shown a slight decline of 0.28% over the past week, while Remus Pharmaceuticals has gained 5.36% in the same period, showcasing its relative strength against the benchmark. Despite the stock's recent upward movement, its long-term performance remains concerning, with significant lo..."
      },
      {
        "title": "Why is Remus Pharma. falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-remus-pharma-fallingrising-3605371",
        "imagepath": "",
        "date": "2025-10-09 00:18:03",
        "description": "As of 08-Oct, Remus Pharmaceuticals Ltd is experiencing a decline in its stock price, currently at 667.70, which represents a decrease of 34.8 points or 4.95%. The stock has hit a new 52-week low of Rs.663.1 today and has underperformed its sector by 4.29%. Over the past week, the stock has decreased by 7.61%, and its year-to-date performance shows a significant drop of 46.53%. Additionally, the stock is trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. Despite this, there has been a notable increase in investor participation, with delivery volume rising by 1082.2% compared to the 5-day average, indicating some interest from investors.\n\nIn the broader market context, the Sensex has shown a positive return of 0.84% over the past week, contrasting sharply with Remus Pharmaceuticals' negative performance. While the benchmark has gained 1.10% over the pas..."
      },
      {
        "title": "Why is Remus Pharma. falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-remus-pharma-fallingrising-3580906",
        "imagepath": "",
        "date": "2025-09-29 23:44:04",
        "description": "As of 29-Sep, Remus Pharmaceuticals Ltd is experiencing a decline in its stock price, currently at Rs. 734.40, which reflects a decrease of Rs. 25.6 or 3.37%. The stock has hit a new 52-week low of Rs. 725.3 today and has underperformed its sector by 3.51%. Additionally, the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Over the past week, the stock has dropped by 8.03%, and its year-to-date performance shows a significant decline of 41.19%. There is also a notable decrease in investor participation, with delivery volume falling by 57.87% compared to the 5-day average, indicating a lack of interest among investors.\n\nIn the broader market context, the Sensex has shown a decline of only 2.25% over the past week, suggesting that Remus Pharmaceuticals is underperforming relative to the benchmark. While the Sensex has gained 4.19% year-to-date, Remus Pharmaceuticals has ..."
      },
      {
        "title": "Why is Remus Pharma. falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-remus-pharma-fallingrising-3568610",
        "imagepath": "",
        "date": "2025-09-24 23:37:51",
        "description": "As of 24-Sep, Remus Pharmaceuticals Ltd is currently priced at 789.45, reflecting an increase of 3.55 or 0.45%. Despite this slight uptick, the stock has been underperforming in the longer term, with a year-to-date decline of 36.78% and a one-year drop of 41.24%. Today's performance summary indicates that the stock hit a new 52-week low of Rs. 765.65 earlier in the day. Additionally, it is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, suggesting a bearish trend. Furthermore, there has been a significant decrease in investor participation, with delivery volume falling by 30.11% compared to the 5-day average, which may indicate waning interest among investors.\n\nIn the broader market context, Remus Pharmaceuticals has experienced a 1-week return of -2.69%, which is notably worse than the benchmark Sensex's decline of only 1.08%. Over the past month, while the stock has dropped ..."
      }
    ],
    "total": 70,
    "sid": "1003851",
    "stock_news_url": "https://www.marketsmojo.com/news/remus-pharmaceuticals-1003851"
  },
  "announcements": "",
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Remus Pharmaceuticals Ltd has declared <strong>5%</strong> dividend, ex-date: 14 Nov 25",
          "dt": "2025-11-14",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Remus Pharmaceuticals Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 04 Jul 25",
          "dt": "2025-07-04",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Is Remus Pharma. technically bullish or bearish?

2025-12-02 09:14:56

Technical Trend Overview

As of 1 December 2025, Remus Pharma’s technical trend shifted from outright bearish to mildly bearish. This subtle change signals a tentative easing of downward pressure but stops short of confirming a bullish reversal. The stock’s current price stands at ₹713.45, having risen from the previous close of ₹690.00, indicating some short-term buying interest. However, this remains well below its 52-week high of ₹1,360.00, highlighting significant depreciation over the past year.

Key Technical Indicators: Mixed Signals

The Moving Average Convergence Divergence (MACD) on the weekly chart is mildly bullish, suggesting some momentum building in the near term. Conversely, the daily moving averages remain bearish, reflecting persi...

How has been the historical performance of Remus Pharma.?

2025-11-12 23:35:06

Answer: The historical performance of Remus Pharma shows significant growth from the fiscal year ending March 2024 to March 2025. Breakdown: In the fiscal year ending March 2025, Remus Pharma reported net sales of 620.36 Cr, a substantial increase from 212.94 Cr in March 2024. The total operating income mirrored this growth, reaching 620.36 Cr compared to 212.94 Cr the previous year. Total expenditure also rose to 574.67 Cr from 183.98 Cr, with notable increases in the purchase of finished goods and other expenses. Operating profit (PBDIT) increased to 50.67 Cr from 31.79 Cr, while profit before tax rose to 47.34 Cr from 30.17 Cr. The profit after tax also saw an increase, reaching 38.42 Cr compared to 24.28 Cr in the prior year. The consolidated net profit for March 2025 was 29.07 Cr, up from 20.52 Cr. Earnings per share improved significantly to 24.68 from 17.45, and the book value per share adjusted to ...

Why is Remus Pharma. falling/rising?

2025-11-05 00:19:54

As of 04-Nov, Remus Pharmaceuticals Ltd is experiencing a price increase, with the current price at 812.50, reflecting a rise of 42.45 or 5.51%. The stock has shown strong performance today, outperforming its sector by 5.98%. Additionally, the stock's delivery volume has significantly increased by 164.55% compared to the 5-day average, indicating rising investor participation. In terms of returns, the stock has gained 23.91% over the past week, while it has increased by 11.23% over the past month. However, it is important to note that the stock is still down 34.93% year-to-date and 36.09% over the past year, suggesting a challenging longer-term trend. In the broader market context, the Sensex has experienced a decline of 1.31% over the past week and an increase of 2.83% over the past month, indicating that while the market has been relatively stable, Remus Pharmaceuticals has significantly outperformed it ...

Is Remus Pharma. technically bullish or bearish?

2025-11-04 08:48:58

As of 3 November 2025, the technical trend has changed from bearish to mildly bearish. The current stance is mildly bearish with weak strength. The weekly MACD is bearish, and the daily moving averages also indicate a bearish trend. While the monthly RSI is bullish, the overall indicators such as the Bollinger Bands and KST on the weekly time frame are mildly bearish. Dow Theory shows a mildly bullish signal on the weekly but remains bearish on the monthly, indicating mixed signals. The recent price action shows a recovery from the previous close, but the overall technical picture leans towards bearish sentiment....

Why is Remus Pharma. falling/rising?

2025-11-03 23:44:00

As of 03-Nov, Remus Pharmaceuticals Ltd is experiencing a price increase, with its current price at 770.05, reflecting a rise of 50.0 or 6.94%. The stock has shown strong performance today, outperforming its sector by 5.64%. In terms of returns, over the past week, the stock has increased by 15.07%, while it has seen a more modest gain of 5.42% over the past month. However, it is important to note that the stock has significantly underperformed on a year-to-date basis, with a decline of 38.33%, and a yearly decline of 41.49%. The stock's moving averages indicate that while it is currently above the 5-day and 20-day averages, it remains below the longer-term averages of 50-day, 100-day, and 200-day, suggesting mixed signals regarding its longer-term trend. Additionally, there has been a notable decrease in investor participation, with delivery volume falling by 35.75% against the 5-day average, which could i...

Why is Remus Pharma. falling/rising?

2025-10-31 23:46:31

As of 31-Oct, Remus Pharmaceuticals Ltd is experiencing a price increase, currently at 720.05, with a change of 32.0, representing a 4.65% rise. The stock has outperformed its sector today by 5.1%, indicating strong investor interest. Additionally, the delivery volume has significantly increased by 105.04% compared to the 5-day average, suggesting rising investor participation. However, while the stock is performing well in the short term, it has seen a decline of 42.34% year-to-date and 44.97% over the past year, which highlights ongoing challenges despite today's positive movement. In the broader market context, the Sensex has shown a slight decline of 0.28% over the past week, while Remus Pharmaceuticals has gained 5.36% in the same period, showcasing its relative strength against the benchmark. Despite the stock's recent upward movement, its long-term performance remains concerning, with significant lo...

Why is Remus Pharma. falling/rising?

2025-10-09 00:18:03

As of 08-Oct, Remus Pharmaceuticals Ltd is experiencing a decline in its stock price, currently at 667.70, which represents a decrease of 34.8 points or 4.95%. The stock has hit a new 52-week low of Rs.663.1 today and has underperformed its sector by 4.29%. Over the past week, the stock has decreased by 7.61%, and its year-to-date performance shows a significant drop of 46.53%. Additionally, the stock is trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. Despite this, there has been a notable increase in investor participation, with delivery volume rising by 1082.2% compared to the 5-day average, indicating some interest from investors. In the broader market context, the Sensex has shown a positive return of 0.84% over the past week, contrasting sharply with Remus Pharmaceuticals' negative performance. While the benchmark has gained 1.10% over the pas...

Why is Remus Pharma. falling/rising?

2025-09-29 23:44:04

As of 29-Sep, Remus Pharmaceuticals Ltd is experiencing a decline in its stock price, currently at Rs. 734.40, which reflects a decrease of Rs. 25.6 or 3.37%. The stock has hit a new 52-week low of Rs. 725.3 today and has underperformed its sector by 3.51%. Additionally, the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Over the past week, the stock has dropped by 8.03%, and its year-to-date performance shows a significant decline of 41.19%. There is also a notable decrease in investor participation, with delivery volume falling by 57.87% compared to the 5-day average, indicating a lack of interest among investors. In the broader market context, the Sensex has shown a decline of only 2.25% over the past week, suggesting that Remus Pharmaceuticals is underperforming relative to the benchmark. While the Sensex has gained 4.19% year-to-date, Remus Pharmaceuticals has ...

Why is Remus Pharma. falling/rising?

2025-09-24 23:37:51

As of 24-Sep, Remus Pharmaceuticals Ltd is currently priced at 789.45, reflecting an increase of 3.55 or 0.45%. Despite this slight uptick, the stock has been underperforming in the longer term, with a year-to-date decline of 36.78% and a one-year drop of 41.24%. Today's performance summary indicates that the stock hit a new 52-week low of Rs. 765.65 earlier in the day. Additionally, it is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, suggesting a bearish trend. Furthermore, there has been a significant decrease in investor participation, with delivery volume falling by 30.11% compared to the 5-day average, which may indicate waning interest among investors. In the broader market context, Remus Pharmaceuticals has experienced a 1-week return of -2.69%, which is notably worse than the benchmark Sensex's decline of only 1.08%. Over the past month, while the stock has dropped ...

View All News